USE OF A CD6 BINDING PARTNER AND METHOD BASED THEREON

USE OF A CD6 BINDING PARTNER AND METHOD BASED THEREON

The present disclosure relates to a Itolizumab antibody or a functional fragment thereof for use in the treatment of Inflammatory Bowel Disease in a subject having an increased number of T helper 17 (Thl7) cells when compared to a healthy subject, wherein the use suppresses the production of the cyt...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MELARKODE, Ramakrishnan, NAIR, Pradip, MANIAN, Bala S, MONTERO CASIMIRO, José Enrique, BARVE, Abhijit, BUGHANI, Usha
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MELARKODE, Ramakrishnan
NAIR, Pradip
MANIAN, Bala S
MONTERO CASIMIRO, José Enrique
BARVE, Abhijit
BUGHANI, Usha
description The present disclosure relates to a Itolizumab antibody or a functional fragment thereof for use in the treatment of Inflammatory Bowel Disease in a subject having an increased number of T helper 17 (Thl7) cells when compared to a healthy subject, wherein the use suppresses the production of the cytokine receptor IL-23R, thereby decreasing inflammation mediated by Thl7 cells.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3936148A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3936148A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3936148A13</originalsourceid><addsrcrecordid>eNrjZDANDXZV8HdTcFRwdjFTcPL0c_H0c1cIcAwK8XMNUnD0c1HwdQ3x8HdRcHIMdnVRCPFwDXL19-NhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAcaWxmaGJhaOhsZEKAEAQq4mhw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF A CD6 BINDING PARTNER AND METHOD BASED THEREON</title><source>esp@cenet</source><creator>MELARKODE, Ramakrishnan ; NAIR, Pradip ; MANIAN, Bala S ; MONTERO CASIMIRO, José Enrique ; BARVE, Abhijit ; BUGHANI, Usha</creator><creatorcontrib>MELARKODE, Ramakrishnan ; NAIR, Pradip ; MANIAN, Bala S ; MONTERO CASIMIRO, José Enrique ; BARVE, Abhijit ; BUGHANI, Usha</creatorcontrib><description>The present disclosure relates to a Itolizumab antibody or a functional fragment thereof for use in the treatment of Inflammatory Bowel Disease in a subject having an increased number of T helper 17 (Thl7) cells when compared to a healthy subject, wherein the use suppresses the production of the cytokine receptor IL-23R, thereby decreasing inflammation mediated by Thl7 cells.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220112&amp;DB=EPODOC&amp;CC=EP&amp;NR=3936148A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220112&amp;DB=EPODOC&amp;CC=EP&amp;NR=3936148A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MELARKODE, Ramakrishnan</creatorcontrib><creatorcontrib>NAIR, Pradip</creatorcontrib><creatorcontrib>MANIAN, Bala S</creatorcontrib><creatorcontrib>MONTERO CASIMIRO, José Enrique</creatorcontrib><creatorcontrib>BARVE, Abhijit</creatorcontrib><creatorcontrib>BUGHANI, Usha</creatorcontrib><title>USE OF A CD6 BINDING PARTNER AND METHOD BASED THEREON</title><description>The present disclosure relates to a Itolizumab antibody or a functional fragment thereof for use in the treatment of Inflammatory Bowel Disease in a subject having an increased number of T helper 17 (Thl7) cells when compared to a healthy subject, wherein the use suppresses the production of the cytokine receptor IL-23R, thereby decreasing inflammation mediated by Thl7 cells.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDANDXZV8HdTcFRwdjFTcPL0c_H0c1cIcAwK8XMNUnD0c1HwdQ3x8HdRcHIMdnVRCPFwDXL19-NhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAcaWxmaGJhaOhsZEKAEAQq4mhw</recordid><startdate>20220112</startdate><enddate>20220112</enddate><creator>MELARKODE, Ramakrishnan</creator><creator>NAIR, Pradip</creator><creator>MANIAN, Bala S</creator><creator>MONTERO CASIMIRO, José Enrique</creator><creator>BARVE, Abhijit</creator><creator>BUGHANI, Usha</creator><scope>EVB</scope></search><sort><creationdate>20220112</creationdate><title>USE OF A CD6 BINDING PARTNER AND METHOD BASED THEREON</title><author>MELARKODE, Ramakrishnan ; NAIR, Pradip ; MANIAN, Bala S ; MONTERO CASIMIRO, José Enrique ; BARVE, Abhijit ; BUGHANI, Usha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3936148A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>MELARKODE, Ramakrishnan</creatorcontrib><creatorcontrib>NAIR, Pradip</creatorcontrib><creatorcontrib>MANIAN, Bala S</creatorcontrib><creatorcontrib>MONTERO CASIMIRO, José Enrique</creatorcontrib><creatorcontrib>BARVE, Abhijit</creatorcontrib><creatorcontrib>BUGHANI, Usha</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MELARKODE, Ramakrishnan</au><au>NAIR, Pradip</au><au>MANIAN, Bala S</au><au>MONTERO CASIMIRO, José Enrique</au><au>BARVE, Abhijit</au><au>BUGHANI, Usha</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF A CD6 BINDING PARTNER AND METHOD BASED THEREON</title><date>2022-01-12</date><risdate>2022</risdate><abstract>The present disclosure relates to a Itolizumab antibody or a functional fragment thereof for use in the treatment of Inflammatory Bowel Disease in a subject having an increased number of T helper 17 (Thl7) cells when compared to a healthy subject, wherein the use suppresses the production of the cytokine receptor IL-23R, thereby decreasing inflammation mediated by Thl7 cells.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP3936148A1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title USE OF A CD6 BINDING PARTNER AND METHOD BASED THEREON
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T14%3A06%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MELARKODE,%20Ramakrishnan&rft.date=2022-01-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3936148A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true